Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
IN BRIEF: EKF Diagnostics launches digital connectivity solution
EKF Diagnostics Holdings PLC - Cardiff-based diagnostics and central laboratory assay maker - Launches EKF Link, a digital connectivity solution for the management of point-of-care analysers and associated data on one centralised platform. EKF Link is a downloadable software package that allows analysers to connect to a hospital or laboratory's IT system, enabling data transfer from these remote analysers for subsequent processing.
Current stock price: 37.60 pence
12-month change: down 50%
By Heather Rydings; heatherrydings@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
Ekf Diagnostics Shares in this article
Latest News
- Oil settles at multi-week high as US-Iran truce buckles under fresh hostilities
51 mins ago - Trump unexpectedly switches back to old Air Force One, sidelining Qatari jet
1 hour ago - Ireland's Manna begins push into U.S. drone delivery "battleground"
1 hour ago - IN BRIEF: Gamma says Epiris' PUSU deadline extended to August
2 hours ago - EARNINGS AND TRADING: SysGroup revenue rises, CFO steps down
2 hours ago - IN BRIEF: DCC announces further deadline extension for bid consortium
2 hours ago - Etihad nearing deal to order 10 Boeing 787 jets, sources say
3 hours ago
Related News
EKF Diagnostics buys back, cancels 50,000 shares
(Sharecast News) - EKF Diagnostics said on Friday that it had purchased 50,000 of its own shares as part of its share buyback programme.
TRADING UPDATES: Tortilla Mexican Grill acts to stem French losses
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
EKF Diagnostics trading in line with management forecasts
(Sharecast News) - EKF Diagnostics said in an update on Tuesday that trading so far in 2026 remained in line with management expectations, supported b...
Follow the stocks
